Related Experiment Videos
Burn excision with intraoperative vasopressin.
B M Achauer1, J Hernández, A Parker
1Division of Plastic Surgery, University of California, Irvine.
The Journal of Burn Care & Rehabilitation
|July 1, 1989
Summary
Arginine-vasopressin reduces blood loss during burn wound surgery, minimizing transfusion needs and risks. This effective treatment benefits patients with both large and small burns, improving care and lowering costs.
Area of Science:
- Medical research
- Surgical innovation
- Burn treatment
Background:
- Intraoperative blood loss is a significant challenge during primary excision of large burns.
- Minimizing blood loss is crucial for patient safety and effective burn care.
Purpose of the Study:
- To investigate the efficacy of arginine-vasopressin in reducing intraoperative blood loss during burn wound excision.
- To assess the safety and potential complications associated with arginine-vasopressin use in burn patients.
Main Methods:
- A clinical investigation was conducted to evaluate the effects of arginine-vasopressin.
- The study focused on measuring intraoperative blood loss during burn wound excision procedures.
Main Results:
- Arginine-vasopressin was found to effectively reduce intraoperative blood loss.
- The treatment was observed to be relatively free of complications.
- Potential benefits were noted for patients with both large and small burns.
Conclusions:
- Arginine-vasopressin is a promising agent for reducing blood loss in burn wound surgery.
- This intervention can decrease the need for banked blood transfusions, thereby reducing associated risks and healthcare costs.